Skip to main content
Equibles

William Lewis

CEO

INSMED Inc (INSM)

Equibles does not estimate personal net worth.

Get an email with a short summary when INSMED Inc publishes a filing, an earnings call transcript or a press release.

Get INSM alerts

About William Lewis

William Lewis is recorded as CEO at INSMED Inc (INSM). The proxy statement of INSMED Inc reports total compensation of $14,467,393 for William Lewis in fiscal 2025, including a base salary of $854,550. Disclosed compensation is on record for 9 fiscal years. William Lewis has spoken on 6 earnings calls across 1 company, most recently for INSMED Inc on May 7, 2026. INSMED Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at INSMED Inc includes William H. Lewis (CEO and Board Member), Paolo Tombesi (CFO), Sara Bonstein (CFO) and 7 others.

William Lewis on recent calls

“Insmed's business is off to a strong start in 2026. Commercially, BRINSUPRI delivered strong sequential growth and continues to outpace all past specialty respiratory launch analogs while establishing a new playbook for excellence for a commercial launch.”
CEO, INSMED Inc Q1 FY2026 Earnings Call ·
“I'm enormously pleased to welcome all of you to Insmed's first earnings call as a company with multiple commercial products. The FDA approval of BRINSUPRI in August marked a new day for patients living with bronchiectasis and a step change in the number of patients Insmed can now serve with its medicines.”
CEO, INSMED Inc Q3 FY2025 Earnings Call ·
“As I reflect on the first half of 2025, I'm enormously pleased with where Insmed stands as a company and the potential impact we can have on the lives of the patients we serve.”
CEO, INSMED Inc Q2 FY2025 Earnings Call ·
“Today, we intend to review the progress from three of the company's main programs, ARIKAYCE, TPIP, and brensocatib. Let's begin with TPIP.”
CEO, INSMED Inc Q1 FY2024 Earnings Call ·
“This quarter has been remarkable for Insmed. We have achieved record-setting revenues for ARIKAYCE for the second consecutive quarter, with growth driven by both the U.S. and Japan.”
CEO, INSMED Inc Q3 FY2023 Earnings Call ·

Affiliation history

Company network

Leadership on record at INSMED Inc

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 INSMED Inc (INSM) $854,550 $14,467,393
2024 INSMED Inc (INSM) $810,000 $10,943,571
2023 INSMED Inc (INSM) $780,000 $10,411,260
2022 INSMED Inc (INSM) $734,850 $7,789,898
2021 INSMED Inc (INSM) $710,000 $7,322,642
2020 INSMED Inc (INSM) $659,720 $6,185,704
2019 INSMED Inc (INSM) $640,500 $7,175,094
2018 INSMED Inc (INSM) $610,000 $5,943,159
2017 INSMED Inc (INSM) $566,500 $4,352,433

Recent activity